Sybron Redux Launches

Credit Suisse and Bank of America are in the market with a $250 million deal for Sybron Dental Specialties.

  • 10 Mar 2006
Email a colleague
Request a PDF

Credit Suisse and Bank of America are in the market with a $250 million deal for Sybron Dental Specialties. The loan, which refinances a previous credit, is a five-year, $250 million revolving credit facility. Pricing on the revolver is LIBOR plus 62.5 basis points. The deal launched on March 2.

The previous $350 million deal, which launched in May 2002, comprised a five-year, $250 million revolver and a seven-year, $200 million term loan "B." Pricing on the revolver was LIBOR plus 2 1/4% and LIBOR plus 2 3/4% on the "B" tranche.

Moody's Investors Service assigned a Ba2 rating to the deal while Standard & Poor's assigned a BB+ rating. Based in Newport Beach, Calif., Sybron is a manufacturer of dental implants and infection prevention products. Their clients include the dental and orthodontic industries. A spokesman at Sybron declined comment as did bankers at B of A. A call to Credit Suisse was not returned.

  • 10 Mar 2006

GlobalCapital European securitization league table

Rank Lead Manager/Arranger Total Volume $m No. of Deals Share % by Volume
1 Citi 3,691 11 20.70
2 Morgan Stanley 2,420 6 13.57
3 Goldman Sachs 2,096 5 11.75
4 BNP Paribas 1,686 6 9.45
5 Barclays 1,565 4 8.78

Bookrunners of Global Structured Finance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Citi 40,734.72 129 10.87%
2 JPMorgan 33,785.84 96 9.02%
3 Wells Fargo Securities 31,464.27 90 8.40%
4 Bank of America Merrill Lynch 29,270.38 93 7.81%
5 Credit Suisse 23,189.41 72 6.19%